Preclinical immunology research has explored how ghrelin associated signaling pathways influence thymic architecture and t cell maturation processes.. Survo’s defining feature is simultaneous nanomolar agonism at human gcgr and glp 1r, confirmed in preclinical pharmacology (zimmermann et al.. The inhibition of tumor growth was not due to a direct cytostatic effect on the tumor cells..
